Case Solution

Robert Chess, Sara Rosenthal
Stanford Graduate School of Business ()

The iPierian case presents a new biotech company that takes advantage of the latest developments in induced pluripotent stem cells (iPSCs). The science in this area is still in its infancy, but change is rapid as new discoveries are made and companies develop applications for the technology. iPierian established himself as one of the first leaders in the field by creating a consistent way to generate large amounts of high-quality iPSCs and then differentiate these cells into motor neurons. The company must choose between three main directions, the development of therapeutics drugs, that it can use to run its business and advance its technology. iPierian must also make this decision in light of the role of leading pharmaceutical companies in the industry, with whom they can collaborate or potentially compete in the race for successful applications for iPSC technology.

We don‘t have the case solution, but we pay up to $50 for yours!

  • Set a reminder to receive an email after your university‘s case study deadline.
  • Upload your case study solution. We will review it for quality.
  • Get your money via PayPal or to your bank account.